The downturn signals valuation risks for investors and could reshape how celebrities launch and manage beauty ventures.
The celebrity beauty boom began in the mid‑2000s when A‑list names turned fragrance and makeup into extensions of their personal brands. By attaching a famous face to a product, companies secured instant media coverage and a built‑in fan base, allowing brands like Kylie Cosmetics and Rare Beauty to scale rapidly across both brick‑and‑mortar and digital channels. This model thrived on the perception of exclusivity and the aspirational pull of celebrity culture, creating a lucrative niche within the broader cosmetics market.
However, the past two years have exposed cracks in that formula. The closures of Gxve Beauty, Flower Beauty, and Cosmoss reflect mounting pressures: market saturation, heightened consumer demand for authentic, indie‑origin products, and the rise of direct‑to‑consumer platforms that lower entry barriers for non‑celebrity founders. Additionally, supply‑chain disruptions and inflation have squeezed margins, making it harder for star‑driven brands to justify premium pricing without delivering differentiated performance. As shoppers become more skeptical of hype‑driven launches, the reliance on name recognition alone no longer guarantees sustainable growth.
Looking ahead, the industry may see consolidation and strategic repositioning. LVMH’s rumored divestiture of its Fenty Beauty stake hints at a reassessment of celebrity‑centric investments, potentially prompting other conglomerates to evaluate similar moves. Surviving brands will likely double down on product innovation, inclusive messaging, and community building to maintain relevance. For investors and marketers, the key takeaway is that celebrity cachet must be paired with genuine value propositions to navigate an increasingly discerning beauty landscape.
Comments
Want to join the conversation?
Loading comments...